# Inolex

Company radar · 100 documents · 2021-01-01–2026-10-14 · updated 2026-10-16

Canonical: https://slate.greyb.com/radar/inolex/innovations

## In one minute

### The conditioning line is built on neutralized amino acid esters
A neutral amino acid with a non-polar side chain is reacted with a long-chain fatty alcohol, and the amine group is neutralized with an acid. The product is a cationic emulsifier that also conditions and lubricates hair, skin and nails. The filings name two preferred versions, leucine isostearyl ester esylate and brassicyl L-isoleucinate esylate, used at 0.1 to 10 percent by weight [1] [2]. A later filing in the same family extends the chemistry to emulsions that hold at pH 5.5 and above, with the alkyl chains specified at 6 to 24 carbons on one side and 6 to 36 on the other [3].

AminoSensyl Ultra MB is the marketed form: cetearyl alcohol with brassicyl valinate esylate, a 100 percent natural replacement for behentrimonium chloride with a natural origin index of 1.0 under ISO 16128 [4] [5]. Henkel put the same chemistry into named retail products and gave Inolex its Best Innovation Contributor award for it [6].

The performance evidence is uneven. A peer-reviewed clinical comparison tested quat-free cationic emulsifier lotions against a quat benchmark [7], and a peer-reviewed piece in the same line calls for cradle-to-grave lifecycle accounting for cosmetic ingredients [8]. The ingredients also carry the specification layer a brand needs for a clean-label claim: ISO 16128 natural origin indices, COSMOS and NATRUE approval, USDA biobased content, Halal and Kosher status [5].

1. [US8105569B2](/?paper=US8105569B2&utm_source=radar&utm_medium=dashboard)
2. [EP2449083B1](/?paper=EP2449083B1&utm_source=radar&utm_medium=dashboard)
3. [EP3139901B1](/?paper=EP3139901B1&utm_source=radar&utm_medium=dashboard)
4. [cosmeticsbusiness.com](https://cosmeticsbusiness.com/inolex-launches-sustainable-btac-replacement-aminosensyl-ultra-mb-207846)
5. [cosmeticsandtoiletries.com](https://www.cosmeticsandtoiletries.com/cosmetic-ingredients/news/22780192/inolex-incorporated-inolex-launches-aminosensyl-ultra-mb-for-deep-moisturization)
6. [cosmeticsbusiness.com](https://cosmeticsbusiness.com/inolex-earns-the-top-award-for-its-aminosensyl)
7. [cosmeticsandtoiletries.com](https://www.cosmeticsandtoiletries.com/cosmetic-ingredients/moisturizing/article/22943033/inolex-incorporated-quatfree-cationic-emulsifierbased-lotions-for-skin-moisturization)
8. [library.scconline.org](https://library.scconline.org/24rjkm4/30)

### The competitive set is the personal care arms of much larger chemical groups
The suppliers Inolex is measured against are divisions of companies far bigger than it. Third-party databases name Symrise, Croda, Evonik, IFF and Stephenson Group as its competitors, and the industry's most-searched ingredient suppliers are led by BASF, Croda, Dow and Lubrizol. Inolex describes itself as "a uniquely independent company". That is a real differentiator in a field of conglomerates, and it also means there is no parent balance sheet behind the build-out it has announced.


### The commitment that can be measured is a launch cadence
Inolex says it aims to introduce five to six new products a year. That is the only output target of its kind the company states publicly, and the recent spending lines up behind it. The marketing, product sustainability, supply chain and application roles added in 2026 are the functions a launch rate needs, and the Ingredient Design Center due to open in 2027 inside The Hall is the facility for prototyping and claim support.


### A second conditioning chemistry is built on amidoamines
ProCondition 22 is brassicamidopropyl dimethylamine, a Brassica-derived amidoamine. It conditions by forming lamellar gel networks, layered liquid crystals that mimic the natural lamellar structure of skin and hair, giving a soft, powdery feel and sealing lifted cuticles on the hair shaft. Its cationic charge is non-permanent, which is the mechanical difference from the quats it replaces.


### The supply side is consolidating and brands are moving upstream
US beauty and personal care recorded 67 M&A transactions announced or completed in 2025, with strategic buyers accounting for nearly 80% of activity and vertical integration among the stated rationales. Persan's deal for Mibelle and kdc/one's combination with Maesa are the year's examples of suppliers merging to offer scale and speed. Brands are also buying into the ingredient layer directly: L'Oréal has backed the biotech supplier Debut, Kao and Unilever have backed Geno, and Olaplex acquired Purvala Bioscience. An independent supplier therefore faces larger competitors on one side and customers who may become owners of its category on the other.


### Commercial execution is the constraint the company is paying to relieve
A sales leader became president while research and development is led by hires from Johnson & Johnson and L'Oréal. Read as a statement of where the bottleneck sits, that puts the constraint on selling and launching rather than on inventing. The bench was bought rather than grown, with Croda, Evonik, Air Products, L'Oréal, Johnson & Johnson, Dow, Ashland, Barentz and Clariant all appearing as prior employers across these appointments.


### The conditioning ingredients draw on different crops
ProCondition Sativa, launched in 2022, was a hemp-derived conditioning and emulsification ingredient. ProCondition 22 is Brassica-derived. SustOleo Embrace is coconut-derived. The same conditioning job is done from three different agricultural inputs, which spreads the exposure to any one crop's price and availability. That is my read of the pattern; the company does not describe it as a hedging strategy.


### In the US, retailers are writing the ingredient-safety standard
The practical safety bar for US beauty is being set by the retailers that sell the products, not by the regulator. The Know Better, Do Better Collaborative, managed by the nonprofit ChemFORWARD and made up of Sephora, Ulta Beauty, Credo, Beautycounter and The Honest Company, published a 2025 report analysing more than 48,000 products and 1.25 million disclosed ingredients. It found 76% of ingredients characterized for safety and 71% verified safer, but 24% still uncharacterized and 3.7% classed as chemicals of concern. The same report calls for clearer definitions of clean beauty, so the standard a supplier has to clear is still moving.


## Overview


Inolex is running one strategy across everything it does: take a legacy chemistry under regulatory or consumer pressure, rebuild it from plant-derived feedstock on a platform that can be re-pointed at different crops, and carry it into the market on a certification dossier rather than on the molecule. The conditioning line does this to quaternary ammonium compounds and silicones; the sun care line does it to the formulation aids that organic UV filters need to stay in solution. The same playbook explains the hiring, the geography and the standards commitments.


## Research

### Preservation is a blend of hydroxamic acid and a diol
One patent claims 4.5 to 15 percent caprylhydroxamic acid, as the only hydroxamic acid in the blend, plus 7 to 95.5 percent of a diol. The diol can be propanediol, methylpropanediol, butylene glycol, 1,2-pentanediol, 1,2-hexanediol, caprylyl glycol, 1,2-decanediol, caprylyl glyceryl ether, ethylhexylglycerin, or a glyceryl monoester of lauric, capric or caprylic acid. The blend is claimed to give broad-spectrum action against Gram-positive and Gram-negative bacteria, yeast and fungi, as a pH-stable alternative to parabens, formaldehyde donors and chlorinated preservatives.


### The same hydroxamic acid chemistry is aimed at skin and hair microbes
A separate family uses hydroxamic acids as active agents rather than preservatives. One filing claims 0.001 to 5.0 percent hydroxamic acid, preferably octanohydroxamic acid, with alkanediols or solubilizers, to inhibit Gram-positive and Gram-negative bacteria including the acne bacterium Propionibacterium acnes and E. coli, yeasts and moulds including Candida and Malassezia furfur, and viruses, without disturbing normal skin flora. A companion filing pairs a hydroxamic acid with alkyl ethers of glycerol at 0.001 to 5.0 percent, for impure skin, dandruff and deodorants. Both are filed under Inolex GmbH.


### A polymeric UV filter was filed and never launched
Inolex's filings include a line of UV-absorbing polymers. The chemistry builds a polyester from a polyol and a dianhydride, opening the anhydride rings to leave pendant carboxylic and hydroxyl groups, then reacting those with an epoxide that carries a UV-absorbing group. The polymer is claimed with a UV-absorbing functionality above 2.0, and later filings cover crosslinked versions of the same idea.


### The polyesteramine platform is being revived
An older Inolex platform is the polyesteramine: a polymer with at least one tertiary amine group, at least one ester linkage and at least one alkyl chain, made from a tertiary-amine polyol, a polyfunctional carboxylic acid and a monofunctional acid or alcohol. The materials are low-melting viscous liquids, with melting points from about -40 to 35 °C and viscosities of 1,000 to 10,000 centipoise at 25 °C, used for their substantivity and lubricity.


### Sun care is built on formulation aids
The 2026 sun care launch is a stabilizer, not a filter. LexFeel Enhance MB is a blend of diheptyl succinate, propylene glycol dibenzoate and a capryloyl glycerin/sebacic acid copolymer. The copolymer forms a polymer network that reduces the recrystallization potential of bemotrizinol and other organic filters, keeping high-SPF formulas stable. Inolex reports that 5 percent of it solubilizes and stabilizes 6 percent bemotrizinol for up to 12 weeks at 4 °C, against less than four weeks for the same amount of C12-15 alkyl benzoate, dibutyl adipate or dicaprylyl carbonate. In-vivo testing cited by the company showed a 25 to 30 percent SPF increase and SPF 50 performance in the systems tested [[https://www.premiumbeautynews.com/en/inolex-launches-lexfeel-enhance-mb,27842,en]].


### The ester platform is re-pointed at skin feel
SustOleo Embrace is the same amino ester platform aimed at a different job. It is a coconut-derived amino ester that changes from a lightweight oil to a cushiony finish on skin, and the company says it holds fragrance on skin for up to 20 hours. In an in-vivo study, a serum with 7.5 percent of it improved dry-skin scaliness by 33 percent and smoothness by 30 percent after one application. It has a natural origin index of 0.85 under ISO 16128, and its biodegradability is predicted by EpiSuite modelling rather than measured.


### The Charlotte plant is where the environmental record is measured
Inolex's flagship manufacturing site is in Charlotte, North Carolina, with regional plants in France, Korea, India and Brazil. The Charlotte site's environmental record is the most concrete process evidence in the company's public material. Charlotte Water gave it a Gold Award for Environmental Excellence in 2026, a year after Silver, on criteria that include a full year of compliance, no slug loading, meaning no large concentrated discharges to the sewer, in 2025, no significant non-compliance for two years, and an active permitted discharge through 2025.


### Prototyping is moving into the Philadelphia headquarters
The Hall opened in Philadelphia in 2023 as a collaborative space, and much of the company's core capability moved into the city centre. An Ingredient Design Center is being built as part of it, due to open in 2027, to give customers rapid prototyping, data and claim support, and to gather consumer feedback.


## Market

### The categories the coalition flags are the ones Inolex sells into
The 2025 report names three priority areas for innovation: lip colorants, emollients, and surfactants, noting that shampoos and conditioners depend on surfactants that, while safe for humans, may pose aquatic toxicity risks. That is Inolex's territory. Its conditioning line is built as a replacement for quaternary ammonium surfactants, and its sensory line sits in emollients. The coalition's call for innovation lands directly on the portfolio, which is demand and scrutiny at the same time.


### US regulation now requires the documentation Inolex markets
Under the Modernization of Cosmetics Regulation Act, US cosmetic facilities must register with the FDA and renew every two years, responsible persons must list each marketed product with its ingredients and update annually, and serious adverse events must be reported within 15 business days. As of 6 January 2026 the FDA's system held 14,299 active facility registrations and 992,907 active product listings. The renewal window for facilities that registered in early 2024 is now open, and missing it can give US Customs grounds to detain a shipment. The US market now demands the kind of ingredient documentation Inolex's certification dossier already supplies, which is a regulatory tailwind for a supplier selling on verified chemistry.


### The show floor rewards actives and biotechnology, while Inolex sells the layer beneath them
in-cosmetics Global 2026 drew 1,069 exhibitors and more than 5,000 products, with 233 launches in its Innovation Zone, an all-time record. The themes that drew the attention were longevity science, exosomes, plant-based PDRN, microbiome support and neurocosmetics. Inolex's marketed line sits in the functional layer under those headlines, in conditioning, emulsifying, stabilizing and sensory, where a formulation has to work but where neither the premium pricing nor the press attention sits. The bet is that being specified inside the formula is worth more than being the story, and the show floor is where that bet is tested.


### The company's size is not legible from public data
Anyone trying to place Inolex in the market has to work from estimates that do not agree. Third-party databases put its annual revenue anywhere from about 27.6 million to 502 million, with a recruiting database at $25-50 million and a business-data provider at $100-500 million. The spread is more than an order of magnitude, and none of the figures has a filing behind it. For a competitor or a customer, the capacity behind the announced build-out is genuinely unknown.


## Strategy

### The US is going direct while Europe stays on distributors
In the US, Inolex is taking account relationships in-house and paying for the infrastructure to serve them: a warehouse network, customer success teams, and manufacturing, inventory and IT platforms. In Europe it is doing the opposite, reaching small brands through an exclusive small-pack distribution partnership with The Ingredients Store in the UK, Ireland, France and Germany, with other European markets served through its existing distributors.


### India is the commitment that cannot be unwound
The India move is the one that carries capital and supply exposure rather than only headcount. A sales office is cheap to open and cheap to close. A registered Indian entity, a manufacturing footprint and a relationship with castor growers in one region are not. With over 80% of the world's castor seed grown in India, a crop, climate or logistics shock there reaches Inolex's global ingredient economics.


### The replacement playbook bets on feedstock and certification
The strategy behind the launches is consistent. Take a legacy chemistry under commercial or regulatory pressure, build a plant-derived substitute on a platform that can be re-pointed at different crops, and carry it into the market on a certification dossier. The conditioning line does this to quaternary ammonium compounds and silicones. The sun care line does it to the formulation aids that organic UV filters need.


### Sun care is a bet on other companies' filters
Inolex does not make UV filters. Its sun care line is the aids that keep other companies' filters in solution and stable, and the 2026 stabilizer was announced within days of the FDA permitting bemotrizinol. The commitment is to be inside the formulation when a new filter arrives, so that each approval in the FDA's remaining pipeline creates demand the company is already positioned to fill.


### The standards positions are commitments the portfolio now has to fit
Inolex has verified 41 products as SAFER with ChemFORWARD and joined the International Collaboration on Cosmetics Safety, alongside membership of the retailer-led transparency effort that produced a 2025 ingredient report. It has committed to carbon reduction through the Science Based Targets initiative and reports to CDP.


### The patent suits have left the scope undefined
Inolex has enforced the same two preservation patents twice, against AE Chemie and then Actera Ingredients, and both cases closed without a court ruling on whether the patents are valid or infringed [[https://www.pacermonitor.com/public/case/53103749/Inolex,_Inc_et_al_v_Actera_Ingredients,_Inc]]. The only judicial signal either case produced went against the company, when the California court declined emergency relief because irreparable harm had not been shown.


### The reporting line has gone quiet
The clearest absence is in disclosure. An outside firm built Inolex's second GRI-referenced sustainability report, explicitly to improve its EcoVadis and CDP rankings, and a corporate sustainability report was released in 2018. Nothing from the recent period appears. The EcoVadis Silver rating announced in 2022 has not been renewed, upgraded or re-scored since.


## Areas

- Operational & Leadership Scaling · 40 documents
- Product Innovation & Launch · 30 documents
- Market Expansion & Commercial Growth · 12 documents
- Legal & IP Defense · 5 documents
- Sustainability & ESG · 11 documents